Paraneoplastic syndromes / Robert B. Darnell, Jerome B. Posner.

Includes bibliographical references and index.

Cover; CONTENTS; SECTION 1 OVERVIEW; 1. DEFINITIONS, CLASSIFICATION, HISTORY, EPIDEMIOLOGY, AND IMPORTANCE; DEFINITIONS; CLASSIFICATION; HISTORY; EPIDEMIOLOGY; IMPORTANCE; 2. CLINICAL FINDINGS, DIAGNOSIS, TREATMENT, AND PROGNOSIS; CLINICAL APPROACH; CLUES TO DIAGNOSIS; PATHOLOGY; TREATMENT; PROGNOSIS; 3. PATHOGENESIS; HISTORICAL VIEWS OF PATHOGENESIS; CURRENT CONCEPTS OF PATHOGENESIS; ANIMAL MODELS; SECTION 2 CLINICAL SYNDROMES; 4. CEREBRAL HEMISPHERE SYNDROMES; CEREBRAL CORTEX (NEOCORTEX); WHITE MATTER DEMYELINATION; BLOOD VESSELS (VASCULITIS).

Hippocampus (limbic encephalitis/encephalopathy)hypothalamus; basal ganglia and thalamus; cognitive and behavioral abnormalities; encephalomyelitis; 5. brainstem and cerebellum; brainstem; cerebellum; 6. spinal cord syndromes; transverse myelopathies; focal myelopathy; movement disorders; 7. cranial nerves; taste and smell (cranial nerves i, v, and vii); visual disturbances (cranial nerve ii); oculomotor nerves (cranial nerves iii, iv, and vi); trigeminal nerve (cranial nerve v); acoustic/vestibular nerve (cranial nerve viii); other cranial nerves; 8. dorsal root ganglia and peripheral nerves.

Dorsal root gangliaperipheral nerve syndromes; 9. neuromuscular junction and muscle; neuromuscular junction disorders; paraneoplastic muscle disorders; 10. non-neurologic paraneoplastic syndromes; endocrine disorders; rheumatic syndromes; autoimmune syndromes; rheumatic vasculitides; other rheumatic disorders; panniculitis; dermatologic syndromes; bone disorders; systemic disorders; section 3 antibodies; 11. paraneoplastic antinuclear and antinucleolar antibodies; anti-hu (anna-1); anti-ri (anna-2); anti-ma1 ma-2; anna-3; zic-4; sox1 (anti-glial nuclear antibody); 12. cytoplasmic antibodies.

Anti-yoanti-tr; anti-cv2 (crmp5); anti -- pca-2; anti-kinase antibodies; anti-ubiquitin conjugating enzyme (ube2e1); anti-nb (beta-nap); anti-proteasome; anti-carp viii; 13. synaptic and channel antibodies; intracellular synaptic antibodies; synaptic receptor antibodies; ion channel antibodies; postsynaptic receptor antibodies; 14. anti-retinal and optic nerve antibodies; carcinoma-associated retinopathy; isolated cone dysfunction; melanoma-associated retinopathy; bilateral diffuse uveal melanocytic proliferation; section 4 cancers; 15. thoracic cancers; lung cancer; thymus cancer.

16. breast, gynecologic, and testicular cancersgynecologic cancers; breast cancer; testicular cancer; 17. hematologic malignancies and miscellaneous solid tumors; lymphomas and leukemias; melanoma; urinary tract cancers; gastrointestinal cancers; colon cancer; gastric and esophageal cancers; head and neck cancers; sarcomas; histiocytosis; index; a; b; c; d; e; f; g; h; i; k; l; m; n; o; p; r; s; t; u; v; w; y; z.

Paraneoplastic syndromes, defined in this book as "disorders caused by cancer, but not a direct result of cancer invasion of the affected organ or tissue", once believed to be rare and esoteric neurologic disorders have assumed increasing importance as an.

eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide